3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Interventions
Carboplatin
44
Paclitaxel
43
liposomal doxorubicin
23
Topotecan
19
Gemcitabine
18
pembrolizumab
17
Cyclophosphamide
17
Bevacizumab
16
Cisplatin
12
niraparib
9
olaparib
8
fludarabine
7
Taxes
7
Docetaxel
7
aldesleukin
6
Nivolumab
6
Doxorubicin
6
1-dodecylpyridoxal
6
oregovomab
5
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Filgrastim
5
rucaparib
4
durvalumab
4
avelumab
4
Surgical Procedures, Operative
4
Melphalan
4
Ipilimumab
4
Interleukin-2
4
Etoposide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Ovarian Neoplasms
×
Pharmacokinetics
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled